Filing Flows › Mimedx Group (MDXG) › Capital expenditures
Mimedx Group (MDXG) capital expenditures by quarter
Mimedx Group's capital expenditures were $166K in Q3 2026 (third quarter 2026), -71% from Q1 2026. Over the last 6 quarters it ranged from $166K (Q3 2026) to $570K (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $166K | -71% | -14% |
| Q1 2026 | $570K | +100% | +51% |
| Q4 2025 | $285K | +48% | — |
| Q3 2025 | $192K | +7% | — |
| Q2 2025 | $179K | -53% | — |
| Q1 2025 | $377K | — | — |
Q3 2026 at a glance
Mimedx Group, Q3 2026: revenue $62.3M (-45% year over year), operating margin -18.8%, net loss $8.7M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Mimedx Group's capital expenditures?
Mimedx Group's capital expenditures were $166K in Q3 2026 (third quarter 2026), -71% from Q1 2026.
How has Mimedx Group's capital expenditures changed?
Over the last 6 quarters it ranged from $166K (Q3 2026) to $570K (Q1 2026).